Paolo Tarantino/X
Apr 4, 2025, 12:12
Paolo Tarantino: Do ADCs make chemotherapy more tolerable?
Paolo Tarantino, Research Fellow presso Dana-Farber Cancer Institute, shared a post on LinkedIn:
“ADCs make chemotherapy more active through improved delivery. But do they make chemotherapy more tolerable?
Usually not. For several reasons, only understood in part.
Of these reasons, and multiple other aspects of ADC toxicities, we will discuss at the 3rd annual ADC Toxicity Summit, held in Boston MA between July 8-10. Hope to see you there.”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 4, 2025, 12:15
Apr 4, 2025, 12:12
Apr 4, 2025, 12:06
Apr 4, 2025, 11:59
Apr 4, 2025, 11:42
Apr 4, 2025, 11:36
Apr 4, 2025, 11:09